cholest-4-en-3-one has been researched along with Colorectal Neoplasms in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, CL; Chen, JJ; Chen, LC; Chen, PY; Chen, YY; Huang, HT; Huang, YB; Kao, YC; Lin, MW; Liu, MY; Wu, DC; Yang, PH | 1 |
1 other study(ies) available for cholest-4-en-3-one and Colorectal Neoplasms
| Article | Year |
|---|---|
Cholest-4-en-3-one attenuates TGF-β responsiveness by inducing TGF-β receptors degradation in Mv1Lu cells and colorectal adenocarcinoma cells.
Topics: Animals; Cholestenones; Colorectal Neoplasms; Epithelial Cells; HT29 Cells; Humans; Lung; Membrane Microdomains; Mink; Phosphorylation; Plasminogen Activator Inhibitor 1; Protein Serine-Threonine Kinases; Proteolysis; Receptor, Transforming Growth Factor-beta Type I; Receptors, Transforming Growth Factor beta; Signal Transduction; Transforming Growth Factor beta1 | 2017 |